Market Outlook

By 2035, the U.S. Connected Diagnostic Devices Market is expected to reach approximately USD 65.12 billion, expanding at a CAGR of 13.35% during the forecast period 2026–2035. The market is estimated at USD 18.60 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. connected diagnostic devices industry is entering a structurally important growth phase as diagnostic hardware transitions from isolated measurement tools into digitally integrated clinical systems. Connected diagnostic devices combine physical sensors, diagnostic instrumentation, wireless or network connectivity, software, cloud infrastructure, clinician dashboards, and increasingly artificial intelligence to capture, transfer, interpret, and operationalize patient data. The category includes connected ECG systems, continuous glucose monitors, digital blood pressure devices, pulse oximeters, digital stethoscopes, smart spirometers, ambulatory diagnostic patches, portable ultrasound systems, connected point-of-care analyzers, networked molecular diagnostic platforms, remote vital-sign devices, and related software-enabled diagnostic ecosystems.

The addressable U.S. market is expanding because healthcare delivery increasingly requires diagnostic information to move with the patient rather than remain inside a hospital department. Hospitals are connecting bedside and ambulatory devices to electronic health records, physician practices are adopting cloud-enabled diagnostic tools, laboratories are networking analyzers across decentralized testing environments, and home-based care programs are deploying devices capable of transmitting physiologic measurements directly to clinical teams.

The underlying patient need is substantial. More than 190 million U.S. adults are estimated to live with at least one chronic condition, while diabetes, hypertension, cardiovascular disease, chronic kidney disease, respiratory disorders, obesity, and aging-related conditions create recurring requirements for measurement and diagnostic surveillance. Diabetes alone affects approximately 40 million Americans, while nearly 120 million U.S. adults have hypertension. These conditions create large populations for connected glucose, cardiovascular, renal-risk, weight, oxygenation, rhythm, and blood-pressure monitoring technologies.

The market has expanded from an estimated USD 10.60 billion in 2021 to USD 16.03 billion in 2024, before reaching USD 18.60 billion in 2025. Historical growth was supported by rapid expansion of remote care infrastructure, normalization of home diagnostics after the COVID-19 period, wider adoption of continuous glucose monitoring, ambulatory cardiac diagnostics, decentralized molecular testing, Bluetooth-enabled vital-sign measurement, hospital interoperability programs, and expanding cloud-based diagnostic data management.

Growth is expected to accelerate in higher-value categories where connectivity directly improves diagnostic yield or workflow economics. These include continuous biosensing, AI-assisted ECG interpretation, connected portable ultrasound, cloud-linked point-of-care molecular diagnostics, multi-parameter remote monitoring, digitally enhanced auscultation, automated diagnostic alerts, and systems capable of integrating device-generated information with electronic health records and clinical decision support.

The U.S. hospital environment is particularly favorable to connected diagnostics. More than 6,000 hospitals, approximately 900,000 staffed beds, and tens of millions of annual hospital admissions create a large installed base for networked diagnostic technologies. At the same time, near-universal certified EHR adoption across non-federal acute care hospitals gives device manufacturers an increasingly mature digital infrastructure into which connected diagnostic products can integrate.

From 2026 through 2035, market competition will shift from individual device performance toward diagnostic ecosystem performance. Healthcare organizations will increasingly evaluate whether a device can acquire reliable data, integrate into existing clinical infrastructure, identify clinically important exceptions, reduce manual documentation, support remote workflows, maintain cybersecurity, improve staff efficiency, and demonstrate measurable clinical or financial value.

The strongest companies will therefore compete across hardware, connectivity, software, analytics, interoperability, security, service, and clinical evidence rather than sensor accuracy alone.

 

Introduction

According to the U.S. Connected Diagnostic Devices Market Report, the industry sits at the intersection of medical diagnostics, digital health, remote care, clinical informatics, artificial intelligence, and consumer-facing medical technology. Connectivity is becoming a fundamental product requirement because modern healthcare increasingly depends on moving diagnostic information between patients, devices, clinicians, laboratories, electronic health records, care-management platforms, and reimbursement workflows.

A traditional diagnostic device performs a measurement and presents the result locally. A connected diagnostic device transforms that same measurement into a longitudinal information asset. Data can be automatically transmitted, trended, compared with previous measurements, analyzed through algorithms, shared with specialists, inserted into an EHR, or escalated when predefined clinical thresholds are reached. This changes the economic role of diagnostic equipment.

For hospitals, connected diagnostics can reduce transcription burden, shorten the time between measurement and clinical action, standardize documentation, support centralized surveillance, improve asset utilization, and extend diagnostic capability outside high-acuity departments. For physician practices, connectivity can support chronic disease management without requiring every measurement to occur during an office visit. For laboratories and point-of-care networks, connected analyzers improve quality control, result distribution, fleet management, inventory visibility, and operational oversight.

The home is also emerging as a legitimate diagnostic environment. Connected glucose systems, blood-pressure monitors, ambulatory ECG patches, pulse oximeters, digital scales, spirometers, sleep diagnostic technologies, and multi-parameter biosensors increasingly generate clinically relevant information outside traditional facilities. This trend aligns with U.S. healthcare economics because payers and providers are attempting to identify deterioration earlier, reduce unnecessary acute-care utilization, manage chronic conditions longitudinally, and preserve hospital capacity.

Interoperability substantially strengthens the market opportunity. Nearly all U.S. non-federal acute care hospitals now use certified EHR systems, and hospital exchange of electronic patient information has become materially more sophisticated. The ability of hospitals to integrate data generated by third-party technologies is particularly important for connected diagnostic manufacturers because the purchasing decision increasingly depends on whether devices can enter an enterprise architecture without creating additional data silos.

The U.S. market also benefits from a powerful innovation ecosystem. Large medtech manufacturers are adding connectivity and AI to established diagnostic portfolios, while specialized digital health companies are developing portable ECG systems, cloud-connected auscultation, wearable biosensors, handheld imaging devices, remote monitoring gateways, and automated interpretation algorithms. The result is a competitive environment in which traditional diagnostics companies increasingly compete with software-oriented and data-oriented healthcare companies.

However, connectivity also introduces new barriers. Cybersecurity has become a product-quality and patient-safety issue. Connected devices must protect patient information, support secure software updates, manage authentication, reduce unauthorized access risk, and remain resilient throughout the product lifecycle. Hospitals increasingly evaluate these capabilities before network-connected medical equipment is approved for deployment.

The commercial opportunity is therefore strongest for companies able to combine clinical accuracy, seamless connectivity, cybersecurity, workflow integration, actionable analytics, reimbursement relevance, and scalable service infrastructure.

 

Key Market Drivers: What’s Fueling the U.S. Connected Diagnostic Devices Market Boom?

The first major growth driver is the scale of chronic disease management in the United States. Chronic conditions create repeated measurements rather than one-time diagnostic events. Hypertension requires longitudinal blood-pressure assessment. Diabetes requires recurrent glucose information. Cardiac arrhythmias can require extended ECG capture because intermittent abnormalities may not appear during a short office-based test. Chronic respiratory disorders benefit from oxygenation and pulmonary-function monitoring. Heart failure management can depend on weight, rhythm, blood pressure, oxygen saturation, and other physiological signals.

This makes connected diagnostics economically attractive because the device can generate data across days or weeks rather than only during a clinical encounter. Connected systems allow clinicians to distinguish an isolated measurement from a meaningful trend.

A second driver is the continued decentralization of diagnostic testing. U.S. healthcare is moving appropriate diagnostics toward physician offices, urgent care centers, retail clinics, outpatient facilities, pharmacies, ambulatory settings, and homes. Portable molecular platforms, handheld imaging, compact ECG systems, connected vital-sign devices, point-of-care blood analyzers, and home diagnostic technologies support this migration.

Decentralization can reduce turnaround time and improve patient convenience, but it also creates a data-governance challenge. Testing performed outside the central laboratory must still reach clinicians, medical records, quality-control systems, and care-management platforms. Connectivity solves part of this problem, making connected platforms strategically more valuable than standalone instruments.

A third driver is the scale of hospital digitization. Near-universal EHR penetration among U.S. hospitals means connected diagnostic technologies are entering an environment where electronic documentation is already standard. Hospital systems are increasingly seeking automatic transfer of measurements rather than manual entry because manual workflows consume nursing and technician time while introducing transcription risk.

This is especially relevant in high-volume environments such as emergency departments, general medical floors, perioperative areas, specialty clinics, cardiology departments, diabetes programs, and ambulatory monitoring services.

A fourth driver is reimbursement support for remote physiologic monitoring and related technology-enabled care. Connected blood-pressure monitors, glucose systems, weight scales, and other devices can support care models in which physiological data are automatically transmitted to providers. Reimbursement does not guarantee device adoption, but it improves the economic case for programs capable of producing clinically useful data while satisfying documentation and patient-management requirements.

A fifth growth driver is the expanding role of artificial intelligence in medical diagnostics. The U.S. regulatory environment has already authorized more than one thousand AI-enabled medical devices across multiple clinical categories. AI increasingly transforms connected diagnostic hardware from a passive data-acquisition tool into an active diagnostic workflow component.

Portable ECG systems can classify rhythm abnormalities. Connected digital stethoscopes can combine heart sounds and ECG signals with algorithms. Imaging systems can assist acquisition and interpretation. Remote monitoring platforms can prioritize patients based on risk rather than forcing clinicians to review every measurement equally. This ability to convert high-volume device data into prioritized clinical information will become central to market growth.

A sixth driver is consumer acceptance of medical-grade biosensing. Continuous glucose monitoring has demonstrated that patients will wear sensors, interact with mobile applications, and share physiological information when the technology provides understandable and actionable feedback. Expansion of over-the-counter glucose biosensing demonstrates the potential for selected diagnostic categories to move beyond prescription-only deployment.

A seventh driver is healthcare labor economics. U.S. health systems continue to face nursing, technical, and physician workflow pressure. Connected diagnostic systems that eliminate manual data entry, automate report generation, enable centralized monitoring, or reduce unnecessary patient travel can create operational value independent of their diagnostic performance.

The next competitive cycle will therefore reward manufacturers that can demonstrate a credible reduction in clinical workload per patient monitored.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in connected diagnostics is increasingly focused on creating diagnostic intelligence rather than simply transmitting measurements. The strongest systems now combine high-quality sensing, automated connectivity, analytics, clinical workflow integration, and decision support.

Continuous biosensing is one of the most important innovation areas. Continuous glucose monitoring has created the most mature model, but the underlying architecture is relevant beyond diabetes. Miniaturized sensors, low-power wireless communication, improved adhesives, longer wear duration, cloud analytics, and mobile applications are enabling devices to capture physiological information for longer periods with lower patient burden.

Cardiac diagnostics are undergoing a similar transformation. Conventional ECG testing captures a short time window. Connected patches, handheld ECG devices, mobile telemetry, and AI-based rhythm classification expand the probability of detecting intermittent abnormalities. Newer portable systems are also reducing the physical footprint required for higher-lead-count ECG acquisition, potentially extending diagnostic-grade recordings into lower-acuity settings.

Digital auscultation is becoming another important connected diagnostic category. Electronic stethoscopes can digitize heart and lung sounds, amplify clinically relevant frequencies, transmit recordings, and pair sound data with ECG or machine-learning algorithms. This has the potential to expand screening capability in primary care, particularly when sophisticated cardiovascular imaging is not immediately available.

Portable diagnostic imaging is also becoming increasingly connected. Handheld and compact ultrasound systems can link probes to smartphones or tablets, store examinations in the cloud, support remote review, and incorporate AI-assisted image acquisition. These capabilities make ultrasound more accessible to emergency medicine, primary care, anesthesia, vascular access, obstetrics, critical care, home care, and rural settings.

Point-of-care diagnostics are becoming more digitally integrated. Molecular analyzers, blood-gas systems, coagulation devices, chemistry platforms, and infectious-disease testing systems increasingly connect to laboratory information systems and enterprise middleware. As point-of-care testing spreads across facilities, manufacturers are differentiating themselves through remote instrument management, automatic result transfer, operator credentialing, quality assurance, and cybersecurity.

Artificial intelligence will become a major value multiplier across these categories. The commercial objective is moving from generating more diagnostic information to generating better-prioritized information. Hospitals and physicians cannot simply absorb unlimited streams of patient-generated data. Algorithms that identify abnormalities, reduce false alerts, summarize longitudinal patterns, or direct attention toward deteriorating patients can materially improve the economics of connected care.

Interoperability innovation is equally important. The device itself may represent only one component of the buying decision. Hospitals increasingly evaluate interfaces with EHRs, laboratory systems, cloud platforms, mobile applications, identity-management systems, and cybersecurity infrastructure. Open interfaces and standards-based integration can therefore create competitive advantage.

Cybersecurity is becoming a design requirement rather than an IT afterthought. Connected diagnostic manufacturers are increasingly expected to manage security throughout the total product lifecycle, including authentication, encryption, vulnerability management, secure updates, software inventories, and post-market response.

Manufacturers that can combine diagnostic performance with enterprise-grade digital infrastructure will be positioned to capture the highest-value contracts.

 

Segmentation Insights

The U.S. Connected Diagnostic Devices Market is segmented on the basis of product category, connectivity architecture, clinical application, end user, and region.

 

By Product Category

Connected Cardiac and Vital-Sign Diagnostic Devices

Connected cardiac and vital-sign devices represent one of the largest segments of the market. The category includes portable ECG systems, ambulatory ECG patches, mobile cardiac telemetry, connected blood-pressure monitors, pulse oximeters, multi-parameter monitors, digital thermometers, smart scales, and digitally connected stethoscopes.

Cardiac monitoring is particularly attractive because diagnostic yield often increases when data are collected over longer periods. Connected ECG patches capable of recording multiple days of continuous electrical activity are increasingly replacing shorter traditional monitoring workflows for selected patients. AI-supported analysis further increases value by filtering large quantities of ECG data into clinically meaningful findings.

Connected blood-pressure monitoring also has a large addressable population because nearly half of U.S. adults have hypertension. Demand is shifting from consumer-oriented logging toward clinician-integrated monitoring in which validated measurements can enter remote-care workflows.

Connected Glucose and Metabolic Diagnostic Devices

Continuous glucose monitoring and connected blood-glucose technologies represent one of the fastest-growing product categories. The market is benefiting from expanding CGM eligibility, improving insurance coverage, simpler sensor application, longer wear duration, smartphone integration, cloud-based clinician reporting, and over-the-counter product availability.

The commercial model is especially attractive because sensors create recurring revenue rather than one-time capital-equipment sales. Manufacturers can also build ecosystem advantages through applications, analytics, caregiver sharing, clinician dashboards, connected insulin technologies, and population-management tools.

Beyond glucose, connected metabolic diagnostics could gradually expand toward ketone measurement and multi-analyte biosensing as sensor technology develops.

Connected Point-of-Care and Molecular Diagnostic Systems

Connected point-of-care diagnostics include molecular analyzers, blood-gas instruments, coagulation devices, chemistry analyzers, immunoassay platforms, hematology systems, infectious-disease testing technologies, and other near-patient diagnostic equipment.

Hospitals increasingly require these systems to integrate with laboratory information systems because decentralized testing can otherwise fragment clinical data and complicate quality control. Connectivity supports automatic result transfer, instrument status monitoring, reagent and consumable tracking, operator management, and remote technical support.

Rapid molecular diagnostics remains especially important in emergency, respiratory, infectious-disease, and antimicrobial-stewardship workflows because faster diagnostic information can influence isolation decisions, therapy selection, and patient disposition.

Connected Diagnostic Imaging and Visualization Devices

This category includes portable ultrasound, handheld ultrasound, digital otoscopes, connected ophthalmic diagnostic tools, digital dermatoscopes, portable imaging accessories, and software-connected visualization systems.

Handheld ultrasound is among the strongest opportunities because miniaturization is converting what was traditionally a departmental capital asset into a mobile diagnostic instrument. Cloud connectivity, AI-assisted guidance, remote image review, and tablet- or smartphone-based interfaces are widening the potential user base.

The segment is expected to gain importance as ultrasound moves deeper into primary care, emergency medicine, ambulatory procedures, maternal health, vascular access, and rural medicine.

Connected Home and Ambulatory Diagnostic Devices

Home and ambulatory technologies include wearable biosensors, home spirometers, connected sleep diagnostic devices, pulse oximeters, ambulatory ECG systems, connected blood-pressure monitors, smart diagnostic scales, and multi-parameter monitoring kits.

Growth depends on reducing patient setup complexity. The most successful products require minimal pairing, automatically transmit data, operate reliably across variable home internet environments, and reduce the amount of technical support required from providers.

Cellular gateways are particularly important for populations in which relying entirely on smartphones or Wi-Fi could create adherence barriers.

 

By Connectivity Architecture

Bluetooth and Bluetooth Low Energy

Bluetooth and BLE dominate many patient-facing devices because they offer low power consumption and straightforward smartphone connectivity. Connected glucose sensors, ECG devices, blood-pressure monitors, pulse oximeters, and portable diagnostic instruments frequently use Bluetooth to communicate with mobile applications.

The principal limitation is that transmission may depend on a correctly paired smartphone or tablet. Manufacturers are therefore improving background synchronization, pairing simplicity, compatibility, and patient onboarding.

Wi-Fi and Enterprise Network Connectivity

Wi-Fi, Ethernet, and institutional network connectivity are particularly important in hospitals, laboratories, clinics, and imaging environments. These technologies support high-volume result transfer and integration with EHRs, laboratory systems, picture archiving systems, central monitoring stations, and enterprise diagnostic platforms.

Healthcare providers favor architectures that can be managed centrally and protected through established hospital cybersecurity controls.

Cellular Connectivity

Cellular connectivity is one of the fastest-growing architectures for remote diagnostic programs because it reduces dependence on patient-owned technology. A preconfigured cellular device or gateway can automatically transmit measurements from a home without requiring the patient to configure Wi-Fi.

This approach is particularly valuable in older populations, chronic disease programs, and health-equity initiatives where digital-literacy assumptions can limit adoption.

NFC and Short-Range Data Transfer

Near-field communication is used selectively where rapid pairing, secure short-distance identification, or low-power interaction is advantageous. Although smaller by revenue than Bluetooth or Wi-Fi, NFC can support user authentication, device setup, sensor activation, and selective data-transfer workflows.

Multi-Protocol and Cloud-Integrated Connectivity

The fastest strategic growth is occurring in systems that support multiple communication methods rather than a single protocol. These devices may use Bluetooth locally, cellular or Wi-Fi for external transmission, and APIs or middleware to integrate with enterprise systems.

Multi-protocol architecture improves flexibility across hospital, ambulatory, and home environments and is increasingly important for manufacturers seeking system-level health-provider contracts.

 

By Clinical Application

Cardiovascular Diagnostics

Cardiology represents a leading application because rhythm disorders, hypertension, heart failure, ischemic disease, and structural abnormalities require repeated diagnostic assessment. Connected ECG, ambulatory cardiac monitoring, digital auscultation, blood-pressure monitoring, portable ultrasound, and AI-supported cardiovascular algorithms are expanding the addressable market.

The category is shifting from episodic testing toward longitudinal surveillance. This creates opportunities for companies able to support both initial diagnosis and ongoing monitoring.

Diabetes and Metabolic Disease

Diabetes is one of the largest connected diagnostic applications because continuous glucose monitoring generates frequent data and directly supports treatment decisions. Approximately 40 million people in the U.S. are estimated to have diabetes, while a substantially larger population has prediabetes.

Expansion of CGM into non-insulin-treated populations and selected over-the-counter markets is increasing the number of potential users beyond the historically intensive insulin-management population.

Infectious Disease and Acute Diagnostics

Connected molecular and point-of-care systems are important in infectious disease because diagnostic turnaround time can directly influence treatment and infection-control workflows. Hospitals and urgent care networks require platforms capable of quickly transferring results into laboratory and clinical systems.

Respiratory testing, sexually transmitted infection diagnostics, hospital-acquired infection testing, sepsis-related diagnostics, and antimicrobial-resistance workflows will remain important sources of demand.

Respiratory and Sleep Diagnostics

Connected pulse oximetry, home spirometry, respiratory-rate monitoring, digital auscultation, portable sleep testing, and multi-parameter biosensors are expanding respiratory diagnostic capability outside traditional pulmonary laboratories.

The category is particularly relevant for COPD, asthma, sleep apnea, post-acute respiratory surveillance, and high-risk chronic disease populations.

Multi-Disease and General Clinical Diagnostics

A broad group of connected diagnostic systems supports general medicine, emergency care, renal disease, maternal health, neurology, oncology, primary care, and multi-condition screening.

Growth will be strongest where connectivity can consolidate multiple measurements into a single patient workflow rather than requiring separate standalone devices.

 

By End User

Hospitals and Health Systems

Hospitals and integrated health systems are the largest end users by value. They purchase connected bedside diagnostics, cardiac monitoring platforms, laboratory analyzers, point-of-care systems, imaging technologies, diagnostic software, and enterprise connectivity infrastructure.

Large systems increasingly standardize equipment across multiple hospitals to reduce integration cost and simplify training, cybersecurity, maintenance, and data management. Enterprise contracts can therefore be strategically more important than individual-device sales.

Physician Offices and Specialty Clinics

Cardiology, endocrinology, primary care, pulmonology, nephrology, women’s health, and other specialty practices are important adopters of compact connected devices.

These settings prioritize products that require minimal technical staff, integrate with practice workflows, produce rapid reports, and support reimbursement. Portable ECG and ultrasound systems are particularly well aligned with physician-office economics.

Diagnostic Laboratories and Point-of-Care Networks

Clinical laboratories remain important purchasers of connected analyzers and middleware, while decentralized point-of-care networks are increasing demand for instrument connectivity.

The economic value of connectivity is substantial when a health system manages hundreds or thousands of testing locations because device status, quality control, operator management, and test results can be centrally supervised.

Urgent Care, Retail Clinics, ASCs, and Outpatient Centers

Urgent care and retail health settings are expanding their diagnostic capabilities to improve same-visit decision making. Compact molecular diagnostics, ECG, ultrasound, vital-sign testing, and connected rapid-testing platforms are particularly relevant.

These facilities emphasize speed, simplicity, small footprint, and predictable per-test economics.

Home Healthcare and Remote Monitoring Providers

Home care represents the fastest-growing end-user group. Devices must be designed differently for this environment because the patient rather than a healthcare professional performs much of the setup and measurement process.

Automatic transmission, strong battery life, low maintenance, cellular connectivity, easy-to-understand interfaces, patient reminders, and clinician dashboards are important purchasing criteria.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Connected Diagnostic Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Market development varies based on population, chronic-disease prevalence, hospital-system concentration, digital-health adoption, academic medical infrastructure, broadband access, outpatient migration, technology investment, and home-care penetration.

The South represented the largest market in 2025 at approximately USD 6.70 billion, while the West represented approximately USD 4.65 billion, the Northeast USD 4.28 billion, and the Midwest USD 2.97 billion. The West is expected to record the fastest expansion through 2035.

South

The South is the largest regional connected diagnostics market and is projected to approach USD 23.70 billion by 2035. Its leadership is supported by population growth, substantial diabetes and cardiovascular burden, rapidly expanding metropolitan health systems, large Medicare populations, rural-access challenges, and increasing investment in remote-care infrastructure.

Texas is the region’s largest opportunity because Houston, Dallas-Fort Worth, Austin, and San Antonio contain major hospital networks, specialty practices, laboratories, and rapidly growing populations. Connected cardiovascular diagnostics, diabetes monitoring, decentralized testing, portable imaging, and remote patient monitoring represent important growth areas.

Florida is particularly attractive for connected cardiac, metabolic, and home diagnostic technologies because of its large older population. Health systems in Miami, Tampa, Orlando, Jacksonville, and South Florida are expanding digital-care capabilities as chronic disease management becomes more distributed.

North Carolina combines major academic centers with fast-growing technology-oriented metropolitan areas. The state is attractive for portable diagnostics, digital cardiology, decentralized testing, and clinical research. Georgia, led by Atlanta, offers a large integrated-provider market with strong demand for diabetes, cardiovascular, and ambulatory diagnostics.

Virginia and Maryland contain sophisticated hospital systems, research networks, government-related healthcare infrastructure, and high levels of health IT adoption. These markets are attractive for enterprise-connected devices requiring sophisticated interoperability.

Tennessee, particularly Nashville, is strategically important because of its concentration of healthcare companies and large hospital-system operators. Connected diagnostics vendors can use the state as both a commercial market and a gateway into multi-state health-system contracts.

South Carolina, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia contain significant chronic disease and rural-access challenges. Their market opportunity differs from highly urbanized states because scalable home diagnostics, cellular-enabled monitoring, compact point-of-care systems, and telehealth-supported diagnostics can create disproportionate value where specialist availability is limited.

The region’s long-term market advantage will come from combining large urban health-system demand with an unusually large opportunity for remote chronic-disease surveillance.

West

The West represented approximately USD 4.65 billion in 2025 and is forecast to reach approximately USD 18.30 billion by 2035, making it the fastest-growing regional market.

California dominates the region because of its population scale, large academic health systems, integrated delivery networks, medtech industry, venture-backed digital health ecosystem, and concentration of technology companies. Connected ultrasound, AI diagnostics, remote monitoring, biosensors, cardiovascular technologies, and cloud-enabled clinical platforms often gain early adoption in California.

Large systems in Los Angeles, San Diego, San Francisco, Sacramento, and the broader Bay Area provide commercially significant enterprise opportunities. California is also strategically important for partnerships between device companies, health systems, AI developers, and cloud infrastructure providers.

Washington is another digitally mature market with strong technology capabilities and sophisticated provider systems. The state’s healthcare organizations are attractive early adopters of interoperability-oriented and cloud-connected diagnostic technologies.

Arizona and Nevada benefit from rapid population growth and increasing older-adult populations, supporting demand for connected cardiology, diabetes monitoring, portable diagnostics, and remote-care programs.

Colorado and Utah have strong integrated health networks and innovative provider environments. Their markets favor solutions that demonstrate measurable clinical workflow improvement rather than simply adding another device endpoint.

Oregon has strong adoption potential for ambulatory and remote diagnostics, while New Mexico offers a distinctive opportunity for connected health technologies that improve access across geographically dispersed populations.

Idaho, Montana, and Wyoming are smaller markets but have compelling use cases for telehealth-supported diagnostics, portable imaging, cellular-enabled remote monitoring, and rural point-of-care systems.

Alaska and Hawaii have unique geographic constraints that can increase the value of remote diagnostics. Connected devices capable of transmitting reliable diagnostic information to specialists can reduce the impact of travel distance and fragmented access.

The West’s defining advantage is the combination of clinical demand and technology development. It is expected to gain national market share as diagnostic care becomes more software-driven, AI-assisted, portable, and home-oriented.

Northeast

The Northeast represented approximately USD 4.28 billion in 2025 and is projected to reach approximately USD 14.20 billion by 2035. The region remains one of the highest-value markets on a per-institution basis because of its concentration of academic medical centers, specialists, research organizations, life-science companies, and advanced health systems.

New York is the largest state market in the Northeast. Major provider systems in New York City and surrounding metropolitan areas operate complex diagnostic environments requiring large-scale monitoring, laboratory connectivity, imaging integration, cardiovascular diagnostics, and enterprise interoperability.

Massachusetts is strategically influential because Boston contains a dense network of academic medical centers, biotechnology companies, medtech firms, research institutions, and digital-health innovators. New connected diagnostic technologies frequently gain clinical validation or early reference-site adoption within this ecosystem.

Pennsylvania provides a large hospital and outpatient market across Philadelphia, Pittsburgh, and surrounding areas. Connected cardiology, diabetes, laboratory diagnostics, and home monitoring are important opportunities.

New Jersey benefits from high population density, major healthcare systems, pharmaceutical and life-sciences infrastructure, and proximity to both New York and Philadelphia.

Connecticut supports premium diagnostic adoption through sophisticated hospital and physician networks. Rhode Island, New Hampshire, Maine, and Vermont are smaller but present meaningful opportunities for remote diagnostics, particularly where connected technologies reduce patient travel or expand specialist reach.

Delaware, within this report’s Northeast commercial grouping, benefits from proximity to major Mid-Atlantic health systems and an established life-science business environment.

The Northeast is expected to grow somewhat more slowly than the West because many provider organizations already operate mature digital infrastructure. However, this maturity increases demand for higher-value replacements, advanced analytics, AI-enabled systems, and cybersecurity-compliant enterprise solutions.

Midwest

The Midwest represented approximately USD 2.97 billion in 2025 and is forecast to reach approximately USD 8.92 billion by 2035. The region provides a stable base of hospital-centered diagnostics combined with increasing interest in remote care across rural populations.

Illinois is the largest Midwest market, led by Chicago’s major academic, community, and integrated provider systems. Large hospital networks support demand for connected patient diagnostics, laboratory platforms, portable imaging, cardiovascular technologies, and enterprise monitoring.

Ohio has a strong concentration of nationally influential healthcare institutions and large regional hospital systems. Advanced cardiology, digital diagnostics, laboratory medicine, and remote monitoring create an attractive market.

Michigan provides large-scale demand through Detroit and other metropolitan health systems, while chronic-disease burden supports connected diabetes and cardiovascular diagnostic programs.

Minnesota is strategically important because of its medtech ecosystem, advanced provider organizations, and long history of medical device innovation. The state’s influence extends beyond its direct market size because manufacturers and clinical organizations can shape national device-development strategies.

Wisconsin and Indiana offer established healthcare networks and stable demand for connected hospital diagnostics and outpatient chronic-care technologies.

Missouri, Iowa, and Kansas support substantial regional referral systems and are attractive for connected cardiac, point-of-care, and home diagnostic technologies.

Nebraska, North Dakota, and South Dakota have lower population density but demonstrate some of the clearest value propositions for connected diagnostics. Remote measurement, cellular transmission, portable imaging, and specialist-supported diagnostic workflows can reduce travel requirements and strengthen rural access.

The Midwest is expected to grow at a more moderate pace than the South or West, but it should remain a strategically reliable market for vendors offering strong service support, durable equipment, integration capability, and cost-effective enterprise contracting.

 

Key Market Players

The U.S. Connected Diagnostic Devices Competitive Landscape is fragmented across traditional medtech manufacturers, diagnostic companies, digital health firms, biosensor developers, cardiovascular monitoring specialists, point-of-care diagnostics companies, and portable imaging manufacturers.

Competition is increasingly ecosystem-based. Major manufacturers can combine devices with software, clinical informatics, middleware, EHR integration, AI, cybersecurity, and long-term service agreements. Specialized companies compete by solving narrow diagnostic workflow problems more effectively than diversified manufacturers.

Some of the key players in the U.S. Connected Diagnostic Devices industry include Abbott Laboratories, Dexcom, Medtronic, GE HealthCare, Philips, Siemens Healthineers, Roche Diagnostics, Danaher Corporation, Becton Dickinson, QuidelOrtho, Bio-Rad Laboratories, Thermo Fisher Scientific, Hologic, Masimo, Baxter International, iRhythm Technologies, AliveCor, Eko Health, OMRON Healthcare, BioIntelliSense, VitalConnect, Butterfly Network, Clarius Mobile Health, FUJIFILM Sonosite, and ZOLL Medical.

Abbott and Dexcom are particularly influential in connected glucose diagnostics, where recurring sensor revenue and mobile data ecosystems are redefining chronic disease monitoring.

GE HealthCare, Philips, and Siemens Healthineers occupy strategically strong positions in hospital diagnostics because of their installed bases in imaging, monitoring, clinical informatics, and enterprise technology.

Roche, Danaher, BD, QuidelOrtho, Bio-Rad, Hologic, and Thermo Fisher participate in laboratory, molecular, near-patient, and point-of-care diagnostics where connectivity increasingly affects workflow efficiency.

Masimo, Baxter, and Philips have significant exposure to connected physiologic monitoring. iRhythm, AliveCor, and Eko are important examples of companies combining specialized cardiovascular hardware with software or AI-based interpretation.

OMRON has a strong position in connected blood-pressure technologies and remote hypertension management. BioIntelliSense and VitalConnect represent the emerging wearable multi-parameter diagnostic segment.

Butterfly Network, Clarius, FUJIFILM Sonosite, GE HealthCare, and other portable imaging manufacturers are driving a shift toward increasingly mobile and connected ultrasound.

Over the forecast period, competitive differentiation will depend on FDA authorization, sensor accuracy, device reliability, diagnostic yield, AI performance, workflow integration, interoperability, cybersecurity, EHR compatibility, reimbursement support, enterprise contracting, patient adherence, and evidence demonstrating reduced downstream healthcare utilization.

 

Recent Developments

Recent developments in the U.S. Connected Diagnostic Devices Market demonstrate how rapidly connectivity is changing medical diagnostics.

In 2024, the U.S. regulatory environment opened an important new pathway for glucose biosensing when the first over-the-counter continuous glucose monitor for adults not using insulin was cleared. Additional over-the-counter glucose systems followed, expanding the potential audience for connected biosensing beyond traditional prescription-only diabetes management.

The expansion of OTC CGM represents more than a product-category development. It demonstrates that clinically meaningful biosensor data can increasingly be captured directly by consumers while remaining connected to digital applications and healthcare information ecosystems.

Connected cardiac diagnostics also advanced substantially. Portable AI-enabled 12-lead ECG technology entered the U.S. market with the ability to identify a broad range of cardiac determinations using a significantly smaller hardware footprint than conventional cart-based ECG systems. This development illustrates how miniaturization and AI can shift diagnostic capability toward physician offices, urgent care environments, mobile care, and other decentralized settings.

Digital auscultation progressed as AI-enabled software received clearance to use ECG and heart-sound inputs to help identify patients who may have reduced left ventricular ejection fraction. This type of technology could make sophisticated cardiovascular screening more accessible in primary-care environments by converting familiar diagnostic tools into AI-assisted connected platforms.

Ambulatory ECG manufacturers continued to improve connected cardiac monitoring systems, including long-duration patch-based devices capable of capturing and transmitting symptomatic and asymptomatic events.

Hospital monitoring also continued moving toward enterprise connectivity. New telemetry technologies are being designed around mobile patients, centralized surveillance, scalable monitoring capacity, and broader connectivity beyond fixed bedside environments.

AI-enabled medical-device development accelerated across diagnostics and imaging. Large manufacturers continue to accumulate regulatory authorizations for AI-enabled products, increasing pressure on competitors to integrate automated acquisition, interpretation, prioritization, and workflow optimization into their hardware portfolios.

Regulatory strategy is also evolving. Federal initiatives increasingly recognize the home as a legitimate healthcare environment, creating an important framework for future connected devices designed for chronic disease management outside hospitals.

The next phase of development is expected to focus on longer sensor wear, fewer patient setup steps, more automated data transmission, clinically explainable AI, multi-parameter sensing, improved battery efficiency, broader EHR integration, stronger cybersecurity, and reimbursement models that link device-generated data with measurable patient outcomes.

 

Conclusion

The U.S. Connected Diagnostic Devices Market Size & Share is positioned to expand from approximately USD 18.60 billion in 2025 to USD 65.12 billion by 2035, representing a 13.35% CAGR during the 2026–2035 forecast period.

The market’s growth is being driven by a structural change in the role of diagnostic devices. Diagnostic hardware is no longer evaluated solely on whether it can generate an accurate measurement. Healthcare providers increasingly require devices to generate accurate information, transmit it automatically, integrate it with existing clinical systems, prioritize abnormalities, support remote workflows, and create measurable operating value.

Continuous glucose monitoring, ambulatory ECG, connected blood-pressure measurement, portable diagnostic imaging, digital auscultation, wearable biosensors, connected molecular testing, point-of-care analyzers, and multi-parameter remote diagnostic devices represent some of the strongest commercial opportunities.

Hospitals will remain the largest end-user segment because enterprise diagnostic connectivity is becoming integral to modern clinical infrastructure. Home and remote monitoring settings will generate the fastest growth as chronic disease management shifts toward longitudinal and preventive models.

From a regional perspective, the South will remain the largest U.S. market, supported by population scale, chronic disease burden, expanding health systems, and substantial demand for remote care. The West will expand fastest, driven by California’s innovation ecosystem, advanced digital-health adoption, and rapidly growing markets such as Arizona, Nevada, Utah, and Colorado. The Northeast will remain a high-value early-adoption region, while the Midwest will provide stable institutional demand and a significant rural connected-care opportunity.

For manufacturers, investors, distributors, health systems, and technology developers evaluating this market, the key strategic question is not whether medical diagnostics will become more connected. The transition is already underway.

The more important questions are which diagnostic categories can generate enough clinical and economic value to justify continuous connectivity, which companies will successfully integrate hardware with software and AI, how healthcare organizations will manage increasingly large volumes of device-generated data, and which platforms will earn sufficient clinical trust to become embedded in long-term care pathways.

The companies best positioned through 2035 will be those that treat connectivity not as a device feature but as an integrated clinical capability combining sensor quality, diagnostic accuracy, cybersecurity, interoperability, AI, workflow economics, clinical evidence, reimbursement alignment, and scalable patient engagement.

 

TABLE OF CONTENT

1. U.S. Connected Diagnostic Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Connected Diagnostic Device Manufacturers
1.6.2. Sensor, Semiconductor and Medical Component Suppliers
1.6.3. Contract Manufacturing and Device Engineering Partners
1.6.4. Cloud, AI, Software and Interoperability Technology Providers
1.6.5. Hospitals and Integrated Delivery Networks
1.6.6. Physician Practices, Diagnostic Laboratories and Point-of-Care Networks
1.6.7. Home Healthcare and Remote Monitoring Providers
1.6.8. Group Purchasing Organizations, Distributors and Channel Partners
1.6.9. Payers, Regulators and Clinical Decision-Makers
What this section provides: This section defines the U.S. connected diagnostic devices market boundary, study scope, methodology, assumptions, technology ecosystem, and stakeholder structure so clients can understand how the market is measured, validated, and differentiated from general consumer wellness and non-connected diagnostic devices.

2. U.S. Connected Diagnostic Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.7.1. Connected Cardiovascular Diagnostics
2.7.2. Continuous Glucose Monitoring and Biosensing
2.7.3. Connected Point-of-Care and Molecular Diagnostics
2.7.4. Portable and Handheld Connected Diagnostic Imaging
2.7.5. Home-Based and Ambulatory Diagnostic Monitoring
2.7.6. AI-Enabled Diagnostic Interpretation and Clinical Decision Support
What this section provides: This section provides decision-makers with a concise view of market size, historical performance, forecast growth, technology direction, competitive intensity, adoption trends, and the highest-value connected diagnostic device opportunities through 2035.

3. U.S. Connected Diagnostic Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Chronic Disease and Aging Population Burden
3.1.2. Expansion of Remote Patient Monitoring and Home-Based Care
3.1.3. Decentralization of Diagnostics Beyond Hospitals and Central Laboratories
3.1.4. Near-Universal Hospital EHR Adoption and Diagnostic Data Integration
3.1.5. Growing Demand for Continuous and Longitudinal Patient Data
3.1.6. Increasing Adoption of AI-Enabled Diagnostic Interpretation
3.1.7. Healthcare Workforce Pressure and Diagnostic Workflow Automation
3.2. Restraints and Their Impact Analysis
3.2.1. Medical Device Cybersecurity and Patient Data Privacy Risk
3.2.2. High Integration and Enterprise Implementation Costs
3.2.3. Interoperability Challenges Across EHR and Clinical IT Platforms
3.2.4. Reimbursement Variability Across Connected Diagnostic Workflows
3.2.5. Patient Adherence and Digital Literacy Constraints
3.2.6. Device Accuracy, False Alert and Clinical Validation Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Expansion of Continuous Biosensing Beyond Traditional Diabetes Management
3.3.2. Connected Ambulatory ECG and AI-Enabled Cardiac Diagnostics
3.3.3. Smart Point-of-Care and Connected Molecular Testing
3.3.4. Handheld Ultrasound and Portable Connected Imaging
3.3.5. Multi-Parameter Home Diagnostic Platforms
3.3.6. Cellular-Enabled Diagnostics for Rural and Underserved Populations
3.3.7. AI-Based Clinical Prioritization and Diagnostic Workflow Automation
3.4. Challenges and Their Impact Analysis
3.4.1. Managing High Volumes of Device-Generated Clinical Data
3.4.2. Alarm Fatigue and Clinician Workflow Burden
3.4.3. Maintaining Connectivity Across Diverse Care Environments
3.4.4. Software Update and Device Lifecycle Management
3.4.5. Demonstrating Health Economic Value to Institutional Buyers
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Connected Device Total Cost of Ownership Analysis
What this section provides: This section evaluates the clinical, technological, economic, reimbursement, interoperability, cybersecurity, and procurement forces influencing connected diagnostic device adoption and helps clients assess both market upside and commercialization risk.

4. U.S. Connected Diagnostic Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization, IoMT and Connected Care
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Connected Medical Device Regulatory Pathways
4.7.2. Software as a Medical Device Considerations
4.7.3. AI-Enabled Medical Device Regulation
4.7.4. Medical Device Cybersecurity Requirements
4.7.5. Post-Market Software and Vulnerability Management
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Remote Physiologic Monitoring
4.8.2. Remote Therapeutic Monitoring Interface
4.8.3. Diagnostic Testing Reimbursement Considerations
4.8.4. Medicare and Commercial Payer Adoption Dynamics
4.9. Healthcare Data Interoperability & EHR Integration Landscape
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives and Public Health Programs
4.12. Impact of Escalating Geopolitical Tensions
4.13. Hospital Value Analysis Committee Decision Framework
What this section provides: This section gives clients a comprehensive understanding of the external operating environment, including regulation, reimbursement, cybersecurity, interoperability, pricing, supply chains, digital health adoption, artificial intelligence, government policy, and institutional procurement requirements.

5. U.S. Connected Diagnostic Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Connected Cardiac and Vital-Sign Diagnostic Devices
5.1.2.1. Connected ECG Systems
5.1.2.2. Ambulatory ECG Patches and Mobile Cardiac Telemetry
5.1.2.3. Connected Blood Pressure Monitors
5.1.2.4. Connected Pulse Oximeters
5.1.2.5. Digital Stethoscopes
5.1.2.6. Connected Multi-Parameter Vital-Sign Monitors
5.1.3. Connected Glucose and Metabolic Diagnostic Devices
5.1.3.1. Continuous Glucose Monitoring Systems
5.1.3.2. Connected Blood Glucose Meters
5.1.3.3. OTC Glucose Biosensors
5.1.3.4. Connected Ketone and Metabolic Monitoring Devices
5.1.3.5. Emerging Multi-Analyte Biosensors
5.1.4. Connected Point-of-Care and Molecular Diagnostic Systems
5.1.4.1. Connected Molecular Diagnostic Analyzers
5.1.4.2. Blood Gas and Electrolyte Analyzers
5.1.4.3. Coagulation Diagnostic Systems
5.1.4.4. Clinical Chemistry and Immunoassay Systems
5.1.4.5. Connected Hematology Systems
5.1.4.6. Infectious Disease Point-of-Care Diagnostic Devices
5.1.5. Connected Diagnostic Imaging and Visualization Devices
5.1.5.1. Handheld and Portable Ultrasound
5.1.5.2. Connected Digital Otoscopes
5.1.5.3. Connected Ophthalmic Diagnostic Devices
5.1.5.4. Digital Dermatoscopes
5.1.5.5. Portable Imaging and Visualization Systems
5.1.6. Connected Home and Ambulatory Diagnostic Devices
5.1.6.1. Wearable Multi-Parameter Biosensors
5.1.6.2. Connected Home Spirometers
5.1.6.3. Connected Sleep Diagnostic Devices
5.1.6.4. Smart Diagnostic Scales
5.1.6.5. Home Diagnostic Monitoring Kits
5.1.6.6. Other Connected Ambulatory Diagnostic Devices
What this section provides: This section identifies the connected diagnostic device categories expected to generate the highest revenue contribution, recurring consumable opportunity, clinical adoption, and growth potential through 2035.

6. U.S. Connected Diagnostic Devices Market – By Connectivity Architecture

6.1. Overview
6.1.1. Segment Share Analysis, By Connectivity Architecture, 2025 & 2035 (%)
6.1.2. Bluetooth and Bluetooth Low Energy
6.1.3. Wi-Fi and Enterprise Network Connectivity
6.1.4. Cellular Connectivity
6.1.4.1. 4G/LTE Connected Devices
6.1.4.2. 5G-Enabled Diagnostic Devices
6.1.4.3. Cellular Diagnostic Gateways
6.1.5. NFC and Short-Range Connectivity
6.1.6. Multi-Protocol and Cloud-Integrated Connectivity
6.1.6.1. Cloud-Native Diagnostic Connectivity
6.1.6.2. API-Enabled Diagnostic Platforms
6.1.6.3. EHR-Integrated Connectivity
6.1.6.4. Device Middleware and Diagnostic Data Hubs
What this section provides: This section evaluates the connectivity architectures supporting data transmission between diagnostic devices, patients, clinicians, laboratories, cloud platforms, and enterprise health IT systems, identifying architectures with the strongest scalability and adoption outlook.

7. U.S. Connected Diagnostic Devices Market – By Clinical Application

7.1. Overview
7.1.1. Segment Share Analysis, By Clinical Application, 2025 & 2035 (%)
7.1.2. Cardiovascular Diagnostics
7.1.2.1. Arrhythmia Detection and Rhythm Monitoring
7.1.2.2. Hypertension Monitoring
7.1.2.3. Heart Failure Surveillance
7.1.2.4. Structural and Functional Cardiac Assessment
7.1.3. Diabetes and Metabolic Disease
7.1.3.1. Type 1 Diabetes Monitoring
7.1.3.2. Type 2 Diabetes Monitoring
7.1.3.3. Gestational Diabetes Monitoring
7.1.3.4. Prediabetes and Metabolic Health Assessment
7.1.4. Infectious Disease and Acute Diagnostics
7.1.4.1. Respiratory Infection Diagnostics
7.1.4.2. Sexually Transmitted Infection Diagnostics
7.1.4.3. Hospital-Acquired Infection Diagnostics
7.1.4.4. Sepsis and Critical-Care Diagnostics
7.1.4.5. Antimicrobial Resistance Testing
7.1.5. Respiratory and Sleep Diagnostics
7.1.5.1. COPD Monitoring and Assessment
7.1.5.2. Asthma Monitoring
7.1.5.3. Oxygenation Monitoring
7.1.5.4. Sleep Apnea Diagnostics
7.1.5.5. Pulmonary Function Assessment
7.1.6. Multi-Disease and General Clinical Diagnostics
7.1.6.1. Primary Care Diagnostics
7.1.6.2. Emergency and Acute Care Diagnostics
7.1.6.3. Renal and Chronic Disease Monitoring
7.1.6.4. Maternal and Women’s Health Diagnostics
7.1.6.5. Other Connected Clinical Diagnostic Applications
What this section provides: This section helps clients identify the disease areas and clinical use cases generating the strongest demand for connected diagnostic technologies and evaluates how diagnostic frequency, patient burden, decentralization, and reimbursement influence adoption.

8. U.S. Connected Diagnostic Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Community Hospitals
8.1.2.3. Integrated Delivery Networks
8.1.2.4. Specialty Hospitals
8.1.3. Physician Offices and Specialty Clinics
8.1.3.1. Primary Care Practices
8.1.3.2. Cardiology Practices
8.1.3.3. Endocrinology and Diabetes Clinics
8.1.3.4. Pulmonology and Sleep Clinics
8.1.3.5. Other Specialty Practices
8.1.4. Diagnostic Laboratories and Point-of-Care Networks
8.1.4.1. Independent Clinical Laboratories
8.1.4.2. Hospital Laboratory Networks
8.1.4.3. Decentralized Point-of-Care Testing Networks
8.1.5. Urgent Care, Retail Clinics and Outpatient Centers
8.1.5.1. Urgent Care Centers
8.1.5.2. Retail Health Clinics
8.1.5.3. Ambulatory Care Centers
8.1.5.4. Other Outpatient Diagnostic Facilities
8.1.6. Home Healthcare and Remote Monitoring Providers
8.1.6.1. Home Health Agencies
8.1.6.2. Remote Patient Monitoring Companies
8.1.6.3. Hospital-at-Home Programs
8.1.6.4. Chronic Care Management Providers
What this section provides: This section identifies the care settings and customer groups expected to drive connected diagnostic device purchasing, recurring sensor utilization, diagnostic decentralization, enterprise connectivity, and home-monitoring adoption.

9. U.S. Connected Diagnostic Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Supplier Sales
9.1.6. Physician Office, Laboratory and Outpatient Procurement
9.1.7. Remote Care and Home Healthcare Procurement
What this section provides: This section explains how connected diagnostic devices are purchased across U.S. healthcare, including direct manufacturer contracting, IDN standardization, GPO influence, distributor relationships, outpatient procurement, and emerging home-care purchasing models.

10. U.S. Connected Diagnostic Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Connected Diagnostic Device Adoption and Healthcare Infrastructure Analysis
10.1.4. Regional Chronic Disease and Diagnostic Demand Analysis
10.1.5. Regional Digital Health, EHR and Remote Care Adoption Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics

10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Connected Diagnostic Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Connected Diagnostic Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Connected Diagnostic Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Connected Diagnostic Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section provides detailed regional and state-level market intelligence covering all 50 U.S. states, enabling clients to compare connected diagnostic device adoption, digital health readiness, chronic disease demand, healthcare infrastructure, procurement behavior, remote-care potential, and state-level commercial opportunities.

11. U.S. Connected Diagnostic Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Abbott Laboratories
11.3.2. Dexcom, Inc.
11.3.3. Medtronic plc
11.3.4. GE HealthCare Technologies Inc.
11.3.5. Philips Healthcare
11.3.6. Siemens Healthineers AG
11.3.7. Roche Diagnostics
11.3.8. Danaher Corporation
11.3.9. Becton, Dickinson and Company
11.3.10. QuidelOrtho Corporation
11.3.11. Bio-Rad Laboratories, Inc.
11.3.12. Thermo Fisher Scientific Inc.
11.3.13. Hologic, Inc.
11.3.14. Masimo Corporation
11.3.15. Baxter International Inc.
11.3.16. iRhythm Technologies, Inc.
11.3.17. AliveCor, Inc.
11.3.18. Eko Health, Inc.
11.3.19. OMRON Healthcare
11.3.20. BioIntelliSense, Inc.
11.3.21. VitalConnect
11.3.22. Butterfly Network, Inc.
11.3.23. Clarius Mobile Health Corp.
11.3.24. FUJIFILM Sonosite, Inc.
11.3.25. ZOLL Medical Corporation
11.4. Competitive Benchmarking by Product Portfolio
11.5. Competitive Benchmarking by Connectivity and Digital Ecosystem
11.6. Competitive Benchmarking by U.S. Clinical Presence
11.7. Competitive Benchmarking by AI and Software Capability
11.8. Partnerships, M&A and Strategic Alliances
Note: Each company profile will include company overview, connected diagnostic device portfolio, U.S. market strategy, financial positioning, connectivity architecture, software and AI capabilities, regulatory approvals, clinical evidence, reimbursement positioning, strategic partnerships, acquisitions, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, device and software portfolio positioning, connectivity capabilities, innovation direction, clinical footprint, and strategic intelligence on major U.S. connected diagnostic device companies.

12. U.S. Connected Diagnostic Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Continuous and Multi-Analyte Biosensing
12.2.2. AI-Assisted Diagnostic Interpretation
12.2.3. Connected Point-of-Care Molecular Diagnostics
12.2.4. Handheld and AI-Guided Diagnostic Imaging
12.2.5. Connected ECG and Digital Auscultation
12.2.6. Multi-Parameter Wearable Diagnostic Platforms
12.2.7. Cellular-Enabled Home Diagnostics
12.2.8. Ambient and Passive Patient Sensing
12.2.9. Cloud-Native Clinical Diagnostic Platforms
12.2.10. Predictive Diagnostic Analytics and Clinical Decision Support
12.3. Emerging Business Trends
12.3.1. Hardware-to-Platform Business Model Transition
12.3.2. Subscription and Recurring Sensor Revenue Models
12.3.3. Enterprise Diagnostic Data Platform Consolidation
12.3.4. Hospital-at-Home Diagnostic Infrastructure
12.3.5. Consumer-to-Clinical Diagnostic Convergence
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Commercialization Readiness Matrix
What this section provides: This section prepares clients for technology disruption, business-model evolution, future adoption scenarios, emerging connected diagnostic categories, investment opportunities, and structural changes expected across the U.S. market through 2035.

13. U.S. Connected Diagnostic Devices Market: Strategic Recommendations

13.1. Recommendations for Connected Diagnostic Device Manufacturers
13.2. Recommendations for Hospitals and Health Systems
13.3. Recommendations for Diagnostic Laboratories and Physician Networks
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Digital Health Startups
13.7. Go-to-Market Strategy Considerations
13.7.1. Hospital and IDN Market Entry
13.7.2. Physician Practice Commercialization
13.7.3. Home and Remote Care Market Entry
13.7.4. Payer and Reimbursement Strategy
13.7.5. Clinical Evidence and KOL Development
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. Interoperability and EHR Integration Strategy
13.10. Cybersecurity and Enterprise IT Positioning Strategy
13.11. AI and Diagnostic Data Monetization Strategy
What this section provides: This section converts market intelligence into actionable recommendations for growth planning, product development, clinical positioning, reimbursement strategy, enterprise selling, channel expansion, interoperability, cybersecurity, investment decisions, and long-term competitive differentiation.

14. U.S. Connected Diagnostic Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Connected Device and Digital Health Classification Limitation
14.7. Regulatory and Reimbursement Change Disclaimer
What this section provides: This section clarifies the report’s market-definition boundaries, data-use terms, forecasting assumptions, regulatory limitations, connected-device classification methodology, and legal conditions applicable to the research.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Connected Diagnostic Devices Market: Market Definition and Scope
TABLE 3: U.S. Connected Diagnostic Devices Market: Research Methodology Framework
TABLE 4: U.S. Connected Diagnostic Devices Market: Key Assumptions
TABLE 5: U.S. Connected Diagnostic Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Connected Diagnostic Devices Market: Stakeholder Analysis
TABLE 7: U.S. Connected Diagnostic Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Connected Diagnostic Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Connected Diagnostic Devices Market: Market Attractiveness Index
TABLE 10: U.S. Connected Diagnostic Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Connected Diagnostic Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Connected Diagnostic Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Connected Diagnostic Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Connected Diagnostic Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Connected Diagnostic Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Connected Diagnostic Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Connected Diagnostic Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Connected Diagnostic Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Connected Diagnostic Devices Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Connected Diagnostic Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 21: U.S. Connected Diagnostic Devices Market: Connected Device Total Cost of Ownership Analysis
TABLE 22: U.S. Connected Diagnostic Devices Market: PESTEL Analysis
TABLE 23: U.S. Connected Diagnostic Devices Market: Porter’s Five Forces Analysis
TABLE 24: U.S. Connected Diagnostic Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 25: U.S. Connected Diagnostic Devices Market: Value Chain Analysis
TABLE 26: U.S. Connected Diagnostic Devices Market: Supply Chain Analysis
TABLE 27: U.S. Connected Diagnostic Devices Market: Digitalization, IoMT and Connected Care Impact
TABLE 28: U.S. Connected Diagnostic Devices Market: Application & Innovation Landscape
TABLE 29: U.S. Connected Diagnostic Devices Market: FDA Regulatory Framework Analysis
TABLE 30: U.S. Connected Diagnostic Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 31: U.S. Connected Diagnostic Devices Market: Healthcare Data Interoperability & EHR Integration Landscape
TABLE 32: U.S. Connected Diagnostic Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 33: U.S. Connected Diagnostic Devices Market: Government Initiatives and Public Health Programs
TABLE 34: U.S. Connected Diagnostic Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 35: U.S. Connected Diagnostic Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 36: U.S. Connected Diagnostic Devices Market: Product Category Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Category
TABLE 38: U.S. Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 39: U.S. Connected Diagnostic Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 40: U.S. Connected Diagnostic Devices Market: Connected Cardiac and Vital-Sign Diagnostic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Connected Diagnostic Devices Market: Connected Glucose and Metabolic Diagnostic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Connected Diagnostic Devices Market: Connected Point-of-Care and Molecular Diagnostic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Connected Diagnostic Devices Market: Connected Diagnostic Imaging and Visualization Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Connected Diagnostic Devices Market: Connected Home and Ambulatory Diagnostic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Connected Diagnostic Devices Market: Connectivity Architecture Snapshot, 2025
TABLE 46: Segment Dashboard; Definition and Scope, by Connectivity Architecture
TABLE 47: U.S. Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 48: U.S. Connected Diagnostic Devices Market: Segment Share Analysis, by Connectivity Architecture, 2025 & 2035 (%)
TABLE 49: U.S. Connected Diagnostic Devices Market: Bluetooth and Bluetooth Low Energy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Connected Diagnostic Devices Market: Wi-Fi and Enterprise Network Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Connected Diagnostic Devices Market: Cellular Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Connected Diagnostic Devices Market: NFC and Short-Range Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Connected Diagnostic Devices Market: Multi-Protocol and Cloud-Integrated Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Connected Diagnostic Devices Market: Clinical Application Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by Clinical Application
TABLE 56: U.S. Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 57: U.S. Connected Diagnostic Devices Market: Segment Share Analysis, by Clinical Application, 2025 & 2035 (%)
TABLE 58: U.S. Connected Diagnostic Devices Market: Cardiovascular Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Connected Diagnostic Devices Market: Diabetes and Metabolic Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Connected Diagnostic Devices Market: Infectious Disease and Acute Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Connected Diagnostic Devices Market: Respiratory and Sleep Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Connected Diagnostic Devices Market: Multi-Disease and General Clinical Diagnostics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Connected Diagnostic Devices Market: End User Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by End User
TABLE 65: U.S. Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 66: U.S. Connected Diagnostic Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 67: U.S. Connected Diagnostic Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Connected Diagnostic Devices Market: Physician Offices and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Connected Diagnostic Devices Market: Diagnostic Laboratories and Point-of-Care Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Connected Diagnostic Devices Market: Urgent Care, Retail Clinics and Outpatient Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Connected Diagnostic Devices Market: Home Healthcare and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Connected Diagnostic Devices Market: Procurement Channel Snapshot, 2025
TABLE 73: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 74: U.S. Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 75: U.S. Connected Diagnostic Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 76: U.S. Connected Diagnostic Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Connected Diagnostic Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Connected Diagnostic Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Connected Diagnostic Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Connected Diagnostic Devices Market: Physician Office, Laboratory and Outpatient Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Connected Diagnostic Devices Market: Remote Care and Home Healthcare Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Connected Diagnostic Devices Market: Regional Snapshot, 2025
TABLE 83: Segment Dashboard; Definition and Scope, by Region
TABLE 84: U.S. Connected Diagnostic Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 85: U.S. Connected Diagnostic Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 86: U.S. Connected Diagnostic Devices Market: Regional Connected Diagnostic Device Adoption and Healthcare Infrastructure Analysis
TABLE 87: U.S. Connected Diagnostic Devices Market: Regional Chronic Disease and Diagnostic Demand Analysis
TABLE 88: U.S. Connected Diagnostic Devices Market: Regional Digital Health, EHR and Remote Care Adoption Analysis
TABLE 89: U.S. Connected Diagnostic Devices Market: Regional Reimbursement and Procurement Dynamics
TABLE 90: West Region U.S. Connected Diagnostic Devices Market: Regional Overview and Trends
TABLE 91: West Region U.S. Connected Diagnostic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 92: West Region U.S. Connected Diagnostic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 98: California Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 99: California Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 100: California Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 101: California Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 103: Washington Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 104: Washington Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 105: Washington Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 106: Washington Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 108: Arizona Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 109: Arizona Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 110: Arizona Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 113: Colorado Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 114: Colorado Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 115: Colorado Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 118: Oregon Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 119: Oregon Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 120: Oregon Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 123: Utah Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 124: Utah Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 125: Utah Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 126: Utah Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 128: Nevada Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 129: Nevada Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 130: Nevada Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Idaho Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 139: Idaho Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 140: Idaho Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 143: Montana Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 144: Montana Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 145: Montana Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 146: Montana Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Alaska Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 154: Alaska Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 155: Alaska Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Connected Diagnostic Devices Market: Regional Overview and Trends
TABLE 164: Northeast Region U.S. Connected Diagnostic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 165: Northeast Region U.S. Connected Diagnostic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 171: New York Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 172: New York Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 173: New York Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 174: New York Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 196: Maine Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 197: Maine Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 198: Maine Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 199: Maine Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 201: Vermont Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 202: Vermont Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 203: Vermont Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 216: Delaware Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: Delaware Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 218: Delaware Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 219: Delaware Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Delaware Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Connected Diagnostic Devices Market: Regional Overview and Trends
TABLE 222: South Region U.S. Connected Diagnostic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 223: South Region U.S. Connected Diagnostic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 229: Texas Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 230: Texas Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 231: Texas Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 232: Texas Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Texas Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 234: Florida Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 235: Florida Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 236: Florida Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 237: Florida Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Florida Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 239: Georgia Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 240: Georgia Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 241: Georgia Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 242: Georgia Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: Georgia Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 259: Alabama Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 260: Alabama Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 261: Alabama Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 262: Alabama Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Alabama Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 289: Virginia Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 290: Virginia Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 291: Virginia Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 292: Virginia Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Virginia Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 294: Maryland Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 295: Maryland Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 296: Maryland Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 297: Maryland Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: Maryland Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Connected Diagnostic Devices Market: Regional Overview and Trends
TABLE 305: Midwest Region U.S. Connected Diagnostic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 306: Midwest Region U.S. Connected Diagnostic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 312: Illinois Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 313: Illinois Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 314: Illinois Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 315: Illinois Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Illinois Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 317: Ohio Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 318: Ohio Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 319: Ohio Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 320: Ohio Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Ohio Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 322: Michigan Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 323: Michigan Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 324: Michigan Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 325: Michigan Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Michigan Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 332: Indiana Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 333: Indiana Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 334: Indiana Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 335: Indiana Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Indiana Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 342: Missouri Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 343: Missouri Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 344: Missouri Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 345: Missouri Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Missouri Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 347: Iowa Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 348: Iowa Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 349: Iowa Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 350: Iowa Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Iowa Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 352: Kansas Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 353: Kansas Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 354: Kansas Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 355: Kansas Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Kansas Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Connected Diagnostic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Connected Diagnostic Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Connected Diagnostic Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Connected Diagnostic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Connected Diagnostic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 372: U.S. Connected Diagnostic Devices Market: Competitive Landscape Snapshot, 2025
TABLE 373: U.S. Connected Diagnostic Devices Market: Key Company Market Share Analysis, 2025
TABLE 374: U.S. Connected Diagnostic Devices Market: Company Positioning Matrix
TABLE 375: U.S. Connected Diagnostic Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 376: U.S. Connected Diagnostic Devices Market: Connectivity and Digital Ecosystem Benchmarking
TABLE 377: U.S. Connected Diagnostic Devices Market: U.S. Clinical Presence Benchmarking
TABLE 378: U.S. Connected Diagnostic Devices Market: AI and Software Capability Benchmarking
TABLE 379: U.S. Connected Diagnostic Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 380: Abbott Laboratories: Company Profile
TABLE 381: Dexcom, Inc.: Company Profile
TABLE 382: Medtronic plc: Company Profile
TABLE 383: GE HealthCare Technologies Inc.: Company Profile
TABLE 384: Philips Healthcare: Company Profile
TABLE 385: Siemens Healthineers AG: Company Profile
TABLE 386: Roche Diagnostics: Company Profile
TABLE 387: Danaher Corporation: Company Profile
TABLE 388: Becton, Dickinson and Company: Company Profile
TABLE 389: QuidelOrtho Corporation: Company Profile
TABLE 390: Bio-Rad Laboratories, Inc.: Company Profile
TABLE 391: Thermo Fisher Scientific Inc.: Company Profile
TABLE 392: Hologic, Inc.: Company Profile
TABLE 393: Masimo Corporation: Company Profile
TABLE 394: Baxter International Inc.: Company Profile
TABLE 395: iRhythm Technologies, Inc.: Company Profile
TABLE 396: AliveCor, Inc.: Company Profile
TABLE 397: Eko Health, Inc.: Company Profile
TABLE 398: OMRON Healthcare: Company Profile
TABLE 399: BioIntelliSense, Inc.: Company Profile
TABLE 400: VitalConnect: Company Profile
TABLE 401: Butterfly Network, Inc.: Company Profile
TABLE 402: Clarius Mobile Health Corp.: Company Profile
TABLE 403: FUJIFILM Sonosite, Inc.: Company Profile
TABLE 404: ZOLL Medical Corporation: Company Profile
TABLE 405: U.S. Connected Diagnostic Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 406: U.S. Connected Diagnostic Devices Market: Disruptive Technologies Impact Matrix
TABLE 407: U.S. Connected Diagnostic Devices Market: Emerging Business Trends
TABLE 408: U.S. Connected Diagnostic Devices Market: Business Opportunities for Startups and Existing Players
TABLE 409: U.S. Connected Diagnostic Devices Market: Investment Prioritization Matrix
TABLE 410: U.S. Connected Diagnostic Devices Market: Technology Commercialization Readiness Matrix
TABLE 411: U.S. Connected Diagnostic Devices Market: Strategic Recommendations for Connected Diagnostic Device Manufacturers
TABLE 412: U.S. Connected Diagnostic Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 413: U.S. Connected Diagnostic Devices Market: Strategic Recommendations for Diagnostic Laboratories and Physician Networks
TABLE 414: U.S. Connected Diagnostic Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 415: U.S. Connected Diagnostic Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 416: U.S. Connected Diagnostic Devices Market: Strategic Recommendations for New Entrants and Digital Health Startups
TABLE 417: U.S. Connected Diagnostic Devices Market: Go-to-Market Strategy Considerations
TABLE 418: U.S. Connected Diagnostic Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 419: U.S. Connected Diagnostic Devices Market: Interoperability and EHR Integration Strategy
TABLE 420: U.S. Connected Diagnostic Devices Market: Cybersecurity and Enterprise IT Positioning Strategy
TABLE 421: U.S. Connected Diagnostic Devices Market: AI and Diagnostic Data Monetization Strategy
TABLE 422: U.S. Connected Diagnostic Devices Market: Scope Limitation
TABLE 423: U.S. Connected Diagnostic Devices Market: Data Use Limitation
TABLE 424: U.S. Connected Diagnostic Devices Market: Forecasting Limitation
TABLE 425: U.S. Connected Diagnostic Devices Market: Legal Disclaimer
TABLE 426: U.S. Connected Diagnostic Devices Market: Third-Party Data Disclaimer
TABLE 427: U.S. Connected Diagnostic Devices Market: Connected Device and Digital Health Classification Limitation
TABLE 428: U.S. Connected Diagnostic Devices Market: Regulatory and Reimbursement Change Disclaimer

List of Figures

FIGURE 1: U.S. Connected Diagnostic Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: Connected Device Total Cost of Ownership Framework
FIGURE 13: U.S. Connected Diagnostic Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 14: U.S. Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 15: U.S. Connected Diagnostic Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 16: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Connected Cardiac and Vital-Sign Diagnostic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Connected Glucose and Metabolic Diagnostic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Connected Point-of-Care and Molecular Diagnostic Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Connected Diagnostic Imaging and Visualization Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Connected Home and Ambulatory Diagnostic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Connectivity Architecture Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Connectivity Architecture Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Bluetooth and Bluetooth Low Energy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Wi-Fi and Enterprise Network Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Cellular Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: NFC and Short-Range Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Multi-Protocol and Cloud-Integrated Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Clinical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Clinical Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Cardiovascular Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Diabetes and Metabolic Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Infectious Disease and Acute Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Respiratory and Sleep Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Multi-Disease and General Clinical Diagnostics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 38: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Physician Offices and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Diagnostic Laboratories and Point-of-Care Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Urgent Care, Retail Clinics and Outpatient Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Home Healthcare and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Physician Office, Laboratory and Outpatient Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Remote Care and Home Healthcare Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 53: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: West Region U.S. Connected Diagnostic Devices Market Share and Leading Players, 2025
FIGURE 55: West Region Market Share Analysis by State, 2025
FIGURE 56: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: California Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Washington Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Arizona Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Colorado Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Oregon Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Utah Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Nevada Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: New Mexico Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Idaho Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Montana Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Wyoming Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Alaska Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Hawaii Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Northeast Region U.S. Connected Diagnostic Devices Market Share and Leading Players, 2025
FIGURE 71: Northeast Region Market Share Analysis by State, 2025
FIGURE 72: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New York Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Massachusetts Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New Jersey Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Pennsylvania Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Connecticut Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Maine Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Vermont Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New Hampshire Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Rhode Island Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Delaware Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: South Region U.S. Connected Diagnostic Devices Market Share and Leading Players, 2025
FIGURE 84: South Region Market Share Analysis by State, 2025
FIGURE 85: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Texas Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Florida Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Georgia Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: North Carolina Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Tennessee Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: South Carolina Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Alabama Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Mississippi Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Louisiana Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Arkansas Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Kentucky Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Oklahoma Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Virginia Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Maryland Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: West Virginia Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Midwest Region U.S. Connected Diagnostic Devices Market Share and Leading Players, 2025
FIGURE 102: Midwest Region Market Share Analysis by State, 2025
FIGURE 103: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Illinois Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Ohio Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Michigan Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Minnesota Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Indiana Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Wisconsin Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Missouri Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Iowa Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Kansas Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Nebraska Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: North Dakota Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: South Dakota Connected Diagnostic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 117: Company Positioning Matrix
FIGURE 118: Key Player Product Portfolio Benchmarking
FIGURE 119: Connectivity and Digital Ecosystem Benchmarking
FIGURE 120: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 121: Connected Diagnostic Device Innovation Roadmap
FIGURE 122: Continuous Biosensing Adoption Roadmap
FIGURE 123: AI-Enabled Diagnostic Interpretation Opportunity Map
FIGURE 124: Connected Point-of-Care Diagnostics Growth Roadmap
FIGURE 125: Handheld and Portable Diagnostic Imaging Growth Roadmap
FIGURE 126: Home and Ambulatory Diagnostics Growth Roadmap
FIGURE 127: Future Market Scenario Analysis, 2026–2035
FIGURE 128: Disruptive Technologies Impact Matrix
FIGURE 129: Emerging Business Trends Matrix
FIGURE 130: Investment Prioritization Matrix
FIGURE 131: Technology Commercialization Readiness Matrix
FIGURE 132: Strategic Growth Roadmap for U.S. Connected Diagnostic Device Companies
FIGURE 133: Go-to-Market Strategy Framework
FIGURE 134: Product Positioning and Portfolio Expansion Framework
FIGURE 135: Interoperability and EHR Integration Strategy Framework
FIGURE 136: Cybersecurity and Enterprise IT Positioning Framework
FIGURE 137: AI and Diagnostic Data Monetization Strategy Framework
FIGURE 138: Report Scope and Disclaimer Framework